|Day Low/High||16.28 / 16.79|
|52 Wk Low/High||5.12 / 25.10|
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Charts of this type are frequently found to be topping patterns.
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Equity markets marked time on Monday, mostly on light volume.
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Assessing Aurora and its peers, strictly on the numbers.
In this day and age, companies must be 'disruptors' or get left in the dust.
Peltz's addition should pacify a persistent critique of the company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
In its first report on cannabis companies, Melius says prices are high.
The stock price of the cannabis company has been on a roll and is poised to move even higher still.
And why I won't recommend any other stocks in these markets, right now.
Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.
There are some big shifts Wednesday in names that have recently been the hottest.
Without Apple doing so well Monday the indices would look much different.
Eight of these 11 trade ideas are in the green, with a few big winners.
Let's check out the charts of four big names in the space.
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
What matters here is the ability to innovate, market, and sell.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.